These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27020628)

  • 1. Hyaluronic acid algorithm-based models for assessment of liver fibrosis: translation from basic science to clinical application.
    Babaei Z; Parsian H
    Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):131-40. PubMed ID: 27020628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.
    Irvine KM; Wockner LF; Shanker M; Fagan KJ; Horsfall LU; Fletcher LM; Ungerer JP; Pretorius CJ; Miller GC; Clouston AD; Lampe G; Powell EE
    Liver Int; 2016 Mar; 36(3):370-7. PubMed ID: 26104018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis.
    El Serafy MA; Kassem AM; Omar H; Mahfouz MS; El Said El Raziky M
    Arab J Gastroenterol; 2017 Jun; 18(2):51-57. PubMed ID: 28579340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid as a non-invasive biomarker of liver fibrosis.
    Neuman MG; Cohen LB; Nanau RM
    Clin Biochem; 2016 Feb; 49(3):302-15. PubMed ID: 26188920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of glycoproteins in the assessment of liver fibrosis: A comparison between laminin, fibronectin, and hyaluronic acid.
    Younesi S; Parsian H
    Turk J Gastroenterol; 2019 Jun; 30(6):524-531. PubMed ID: 31144658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More on serum markers of liver fibrosis:are they still clinically limited?
    Vajro P
    J Gastrointestin Liver Dis; 2010 Sep; 19(3):338-9; author reply 339. PubMed ID: 20922204
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C.
    Catanzaro R; Milazzo M; Arona S; Sapienza C; Vasta D; Arcoria D; Marotta F
    Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):500-7. PubMed ID: 24103280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C.
    El-mezayen HA; Toson el-SA; Shiha GE
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):69-76. PubMed ID: 23011038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
    Cheong JY; Um SH; Seo YS; Shin SS; Park RW; Kim DJ; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB; Park YN; Cho SW
    Hepatogastroenterology; 2012; 59(120):2592-7. PubMed ID: 23178625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    Suzuki A; Angulo P; Lymp J; Li D; Satomura S; Lindor K
    Liver Int; 2005 Aug; 25(4):779-86. PubMed ID: 15998429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
    Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
    J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.
    Naveau S; Raynard B; Ratziu V; Abella A; Imbert-Bismut F; Messous D; Beuzen F; Capron F; Thabut D; Munteanu M; Chaput JC; Poynard T
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):167-74. PubMed ID: 15704051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
    Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of non-invasive serum markers for predicting liver fibrosis in Egyptian patients with chronic HCV infection.
    El Guesiry D; Moez P; Hossam N; Kassem M
    Egypt J Immunol; 2011; 18(2):1-12. PubMed ID: 23082465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enhanced liver fibrosis (ELF) test in diagnosis and management of liver fibrosis.
    Day JW; Rosenberg WM
    Br J Hosp Med (Lond); 2018 Dec; 79(12):694-699. PubMed ID: 30526098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
    Hashimoto E; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):501-3. PubMed ID: 19368628
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.
    Malik R; Chang M; Bhaskar K; Nasser I; Curry M; Schuppan D; Byrnes V; Afdhal N
    J Gastroenterol Hepatol; 2009 Apr; 24(4):564-8. PubMed ID: 19378390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.